Aura Biosciences Q3 EPS $(0.29) Beats $(0.37) Estimate

Benzinga · 2d ago
Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.37) by 21.62 percent. This is a 27.5 percent increase over losses of $(0.40) per share from the same period last year.